Log In
BCIQ
Print this Print this
 

levodopa/carbidopa (ND0612L)

Also known as: ND0612

  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionLow-dose formulation of liquid levodopa and carbidopa delivered via a continuous, subcutaneous belt pump
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced Parkinson's disease (PD); Treat moderate Parkinson's disease (PD); Treat moderate to severe Parkinson's disease (PD); Treat Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today